INFLAMMATORY PATHWAYS AS NEW THERAPEUTIC TARGETS FOR THE TREATMENT OF SCHIZOPHRENIA : 1
ADIPOKINES AND ENDOTHELIAL DYSFUNCTION : 2
AGEING, INFLAMMATION, AND VASCULAR DYSFUNCTION : 3
BIOLOGICAL MEDICINAL PRODUCTS: CONCEPT AND REGULATION : 4
CONTRIBUTION AND CLINICAL USE OF BIOLOGICAL DRUGS: MILESTONES AND PROSPECTS : 5
CHALLENGE AND OPPORTUNITIES OF MODEL BASED DRUG DEVELOPMENT : 6
DELAY OF ALZHEIMER-LIKE PATHOLOGY IN MICE WITH 7,8-DIHYDROXYFLAVONE : 7
EVALUATION EXPERIENCE IN RESEARCH PROJECTS : 8
EXPERIENCES OF EVALUATION IN CLINICAL PHARMACOLOGY: OUR MODEL IN THE JOINT DEGREE OF MEDICINE UAB-UPF : 9
FACING VARIABILITY IN PHARMACOLOGY: USES AND CHALLENGES OF MODELLING AND SIMULATION : 10
GENETIC SCREENS AS A POWERFUL TOOL TO UNCOVER PHARMACEUTICAL TARGETS : 11
INTERACTION OF SEROTONIN 5-HT2A RECEPTOR AND METABOTROPIC GLUTAMATE RECEPTOR MGLUR2 IN THE PHARMACOLOGICAL ACTIONS OF HALLUCINOGENIC AND ANTIPSYCHOTIC DRUGS : 12
LONG-ACTING INJECTABLE ANTIPSYCHOTICS: FROM PHARMACOKINETICS TO THE BENEFITS FOR THE PATIENT : 13
MECHANISMS OF ACTION OF TAPENTADOL. AN OPIOID AND MORE… : 14
MENOPAUSE, SEX HORMONES AND ENDOTHELIAL FUNCTION : 15
MODELING & SIMULATION FOR THE DOSE PERSONALIZATION IN ONCOLOGY THERAPIES : 16
MULTIFUNCTIONAL ANALGESICS : 17
NALMELFENE BLOCKS THE NEUROINFLAMMATION INDUCED BY ETHANOL : 18
PHARMACOLOGICAL MODULATION OF THE ENDOTHELIAL DYSFUNCTION THROUGH NUCLEAR RECEPTOR ACTIVATION : 19
REGULACIÓN NEUROFARMACOLÓGICA DE LA ACTIVIDAD CORTICAL CEREBRAL Y SU INTERÉS EN LA BÚSQUEDA DE NUEVAS DIANAS EN ESQUIZOFRENIA : 20
SIMULATION AND THERAPEUTIC DRUG MONITORING NEEDS IN CLINICAL PRACTICE : 21
STRATEGIES FOR THE SYNTHESIS OF DUAL ACTING DRUGS : 22
THE ACADEMIC CAREER: WHICH SHOULD BE THE FORMATION OF A UNIVERSITY TEACHER? : 23
THE ASSESSMENT OF PHARMACOLOGY'S LEARNING UNDER REVIEW : 24
THE BASIS OF THE TEACHING ASSESSMENT : 25
THE EVALUATION IN PROBLEM-BASED LEARNING TEACHING: A PRAGMATIC APPROACH : 26
THE TRANSCRIPTION FACTOR T-BET IN INNATE LYMPHOID CELLS: A POTENTIAL THERAPEUTIC TARGET FOR INTESTINAL INFLAMMATORY DISEASES : 27
5-HT2 RECEPTOR BLOCKADE ENHANCES SYMPATHO-INHIBITORY SEROTONERGIC ACTIONS AT CARDIOVASCULAR LEVEL IN RAT : 28
RICE BRAN ENZYMATIC EXTRACT REDUCES ATHEROSCLEROTIC LESIONS IN APO E (-/-) MICE : 29
PHARMACOPHORE OF DRUGS THAT INCREASE IKIR2.1 : 30
ROLE OF RGS5 IN THE ANTIHYPERTENSIVE EFFECTS OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-β ACTIVATION IN ANGIOTENSIN II-INFUSED MICE : 31
MITOCHONDRIAL DYSFUNCTION AFFECTS THE CAPACITATIVE CALCIUM ENTRY AND INDUCE CALCIUM OVERLOAD IN HYPERTENSIVE RATS : 32
ROLE OF ETA AND ETB RECEPTORS IN THE ENDOTHELIN-1-INDUCED AUGMENTED REACTIVE OXYGEN SPECIES (ROS) PRODUCTION AND ENDOTHELIAL DYSFUNCTION IN OBESITY : 33
CHRONIC CARVEDILOL TREATMENT DECREASES THE EXPRESSION OF β1-ADRENOCEPTORS AND GRKS IN LEFT VENTRICLE FROM HEART FAILURE PATIENTS AND WISTAR RATS : 34
TYROSINE HYDROXYLASE PHOSPHORYLATION IS AUGMENTED AFTER COMBINATION OF BINGE ETHANOL AND MDMA IN MICE : 35
AGEING AND LACK OF ESTROGENS INCREASE VASCULAR CONTRACTION TO THROMBOXANE A2 THROUGH RHO KINASE IN MOUSE AORTA : 36
HYDROGEN PEROXIDE-MEDIATED ENDOTHELIUM DEPENDENT RELAXATIONS OF RENAL ARTERIES ARE ENHANCED IN OBESITY : 37
EXTRA VIRGEN OLIVE OIL POLYPHENOL DERIVATIVES DOWNREGULATE LPS-INDUCED INFLAMMATORY RESPONSE IN MURINE PERITONEAL MACROPHAGES SUPPRESSING NFKB SIGNALLING PATHWAY : 38
SQUALENE MODULATES MYELOID CELLS ACTIVATION THROUGH MAPK, NRF2, PPARΓ AND MMP SIGNALLING PATHWAYS SQUALENE MODULATES MYELOID CELLS ACTIVATION THROUGH MAPK, NRF2, PPARΓ AND MMP SIGNALLING PATHWAYS : 39
OLEOYLETHANOLAMIDE AND PALMITOYLETHANOLAMIDE SHOW ANTIINFLAMMATORY AND NEUROPROTECTIVE PROPERTIES BUT ONLY OEA DISRUPTS ANHEDONIA AFTER LPS SYSTEMIC ADMINISTRATION IN RATS : 40
THE ALPHA2-ADRENOCEPTOR OF ADRENOMEDULLARY CHROMAFFIN CELLS: A NEW TARGET FOR THE TREATMENT OF NEUROPATHIC PAIN? : 41
DEVELOPMENT OF PHENOTYPICAL IN VITRO MODELS IN PAIN FOR EARLY DRUG DISCOVERY : 42
RILPIVIRINE INDUCES LEUKOCYTE-ENDOTHELIAL CELL INTERACTIONS : 43
INTERFERENCE OF ABACAVIR WITH THE PURINERGIC SIGNALLING PATHWAY : 44
SELECTIVE ACTIVATION OF α7 NICOTINIC ACETYLCHOLINE RECEPTOR (NACHRα7) INHIBITS MUSCULAR DEGENERATION IN MDX DYSTROPHIC MICE : 45
COLONIC BACTERIAL TRANSLOCATION IS INVOLVED IN THE NEUROINFLAMMATION DETECTED IN A DEPRESSION-LIKE MODEL THROUGH ACTIVATION OF MAPK PATHWAYS : 46
THE ATYPICAL ANTIPSYCHOTIC PALIPERIDONE PREVENTS BRAIN INFLAMMATION THROUGHOUT INNATE IMMUNE MECHANISMS : 47
FUSION PORE KINETICS IN C57 MOUSE CHROMAFFIN CELLS CHALLENGED WITH DIFFERENT SECRETAGOGUES : 48
CHONDROITIN SULFATE ELICITS DIFFERENT [CA2+]C SIGNALS AT THE VARIOUS SUBTYPES OF HIPPOCAMPAL CELLS : 49
ANTI-INFLAMMATORY MECHANISMS OF ACTION OF OXYLIPINS ISOLATED FROM MICROALGAE : 50
EXPOSURE-RESPONSE ANALYSIS OF PERIPHERAL NEUROPATHY IN PATIENTS WITH SOLID TUMORS TREATED WITH PM060184 : 51
PHARMACOKINETICS/PHARMACODYNAMICS POPULATION MODELING OF TRANSAMINITIS IN CANCER PATIENTS TREATED WITH KAHALALIDE F : 52
PHARMACOKINETIC AND PHARMACODYNAMIC MODELING OF NEUTROPENIA FOR LURBINECTEDIN : 53
NOVEL NEGATIVE GATING MODULATORS OF KCA2/3 POTASSIUM CHANNELS AS PHARMACOLOGICAL TOOLS FOR NOVEL TRATMENTS : 54
GAQ INDUCES APOPTOSIS THROUGH A NOVEL INTERACTING REGION WITH THE EFFECTOR PKCZ : 55
RESIDUE HIS264 IN EXTRACELLULAR LOOP 3 OF ADENOSINE A2A RECEPTOR IS CRITICAL FOR THE KINETICS OF LIGAND BINDING : 56
TRIGLYCERIDE-RICH LIPOPROTEINS MODULATE THE NIACIN-INDUCED PRODUCTION OF THE VASODILATOR PGD2 IN HUMAN MACROPHAGES : 57
NOVEL MARKERS TO EVALUATE IMMUNOMODULATORY EFFECTS OF ANTIBIOTICS IN DSS-COLITIS: MICRO-RNA EXPRESSION AND MICROBIOTA POPULATIONS : 58
EFFECT OF CYP2C9 AND CYP2C8 POLYMORPHISMS ON PHARMACOKINETICS OF IBUPROFEN ENANTIOMERS : 59
PHARMACOLOGY OF NATIVE α6β4 NICOTINIC ACETYLCHOLINE RECEPTORS IN HUMAN ADRENAL CHROMAFFIN CELLS : 60
NEUROTROPHIN-3 MODULATES THE FUNCTIONALITY OF ENDOTHELIAL β3-ADRENOCEPTORS IN MOUSE AORTA : 61
REPLACEMENT OF LABORATORY WORK BY AUDIOVISUAL SIMULATIONS IN PHARMACOLOGY TEACHING: THE STUDENTS’ POINT OF VIEW : 62
MULTICENTRIC OSTEOARTHRITIS INTERVENTION STUDY WITH SYSADOA (MOVES): EFFECTS OF COMBINED GLUCOSAMINE HYDROCHLORIDE AND CHONDROITIN SULFATE VS CELECOXIB FOR PAINFUL KNEE OSTEOARTHRITIS : 63
CARDIOPROTECTION EXERTED BY LABDANE DITERPENES IS RELATED TO ACTIVATION OF AKT PATHWAYS IN ISOLATED RAT HEARTS SUBJECTED TO ISCHEMIA/REPERFUSION : 1
5-HYDROXYTRYPTAMINE MODULATION OF VAGALLYINDUCED BRADYCARDIA IN FLUOXETINE-TREATED RAT : 2
SEVOFLURANE INDUCED LOWER POSTOPERATIVE RELEASE OF TROPONIN 1 AND NT-PROBNP THAN PROPOFOL IN PATIENT SUBJECTED TO OFF-PUMP CORONARY ARTERY BYPASS GRAFT SURGERY : 3
ZOFENOPRIL AVOIDS CARDIOVASCULAR ALTERATIONS IN ANGIOTENSIN II INFUSED MICE : 4
ROLE OF OXIDATIVE STRESS IN HYPERTENSION AND VASCULAR DYSFUNCTION ASSOCIATED TO ACTIVATION OF TLR4 BY ANGIOTENSIN II : 5
NATRIURETIC EFFICIENCY OF TORASEMIDE-PR (10 MG) COMPARED WITH FUROSEMIDE-IR (40 MG) IN PATIENTS WITH CHF : 6
VASCULAR SMOOTH MUSCLE CONTRACTILE MECHANISMS IN HUMAN MESENTERIC ARTERIES AND THEIR AGEING ALTERATION : 7
PIOGLITAZONE IMPROVES CEREBRAL VASCULAR FUNCTION IN OBESE AND LEAN ZUCKER RAT : 8
DIETARY INTAKE OF LYCOPENE DECREASES THE CARDIOVASCULAR RISK IN SPONTANEOUSLY HYPERTENSIVE RATS : 9
REACTIVE HYPEREMIA AFTER RAT FOCAL CEREBRAL ISCHEMIA: MIDDLE CEREBRAL ARTERY CHANGES AND BENEFITS OF URIC ACID TREATMENT : 10
CHRONIC ACTIVATION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-B PREVENTS ENDOTHELIAL DYSFUNCTION INDUCED BY HIGH-FAT DIET IN MICE : 11
ROLE OF COX-2/MPGES-1 AXIS ON VASCULAR REMODELING IN HYPERTENSION : 12
ENDOTHELIAL F-ACTIN DISRUPTION PREVENTS LOSS OF EDHF DILATION FOLLOWING THROMBOXANE STIMULATION IN RAT CEREBRAL ARTERIES : 13
SIRT3 BLOCKS LIPID-INDUCED INFLAMMATION IN THE HEART : 14
STUDY OF CILOSTAZOL IN PATIENTS WITH INTERMITTENT CLAUDICATION. RELATIONSHIP BETWEEN CLINICAL PARAMETERS, OXIDATIVE STRESS AND NUMBER OF ENDOTHELIAL PROGENITOR CELLS : 15
PHARMACOLOGICAL GATING MODULATION OF ENDOTHELIAL KCA3.1 CHANNELS AND EDH-TYPE RELAXATION : 16
GLUCOCORTICOIDS AS MODULATORS OF EXPRESSION AND ACTIVITY OF ANTITHROMBIN III: CLINICAL RELEVANCE : 17
EVALUATION OF SDF1 ON THE FUNCTIONALITY OF ENDOTHELIAL PROGENITOR CELLS IN PATIENTS WITH DIABETES MELLITUS TYPE 2 OR HYPERCHOLESTEROLEMIA : 18
VASCULAR REPAIR AND THE INVOLVEMENT OF ADHESION MOLECULES IN PATIENTS WITH HYPERTENSION AND HYPERCHOLESTEROLEMIA : 19
PERIVASCULAR FAT ADIPOKINES OF PROSTANOID NATURE EXERT VASOACTIVE EFFECTS ON MESENTERIC RESISTANCE ARTERIES OF WKY AND SHROB RATS : 20
EFFECTS OF SPHINGOMYELINASE INHIBITORS AND QUERCETIN IN A RAT MODEL OF HEMORRAGHIC TRAUMATIC SHOCK AND REPERFUSION : 21
KV7 CHANNELS DETERMINE REGIONAL DIFFERENCES IN THE SENSITIVITY TO CAMP, HYPOXIA AND HIGH GLUCOSE IN CORONARY ARTERIES : 22
MICROVASCULAR ENDOTHELIAL DYSFUNCTION BY SOLUBLE DIPEPTIDYL PEPTIDASE-4: RELEASE OF THROMBOXANE-A2 : 23
MONOSODIUM URATE CRYSTAL INDUCED MACROPHAGE INFLAMMATION IS ATTENUATED BY CHONDROITIN SULFATE: PRE-CLINICAL MODEL FOR GOUT PROPHYLAXIS? : 24
CHONDROPROTECTIVE ACTIVITY OF A COMBINATION OF CHONDROITIN SULFATE, GLUCOSAMINE AND A NATURAL INGREDIENT RICH IN HYALURONIC ACID : 25
ANTI-INFLAMMATORY AND JOINT PROTECTIVE EFFECTS OF A POLYPHENOLIC EXTRACT FROM EXTRA VIRGIN OLIVE OIL IN TYPE II COLLAGEN-INDUCED ARTHRITIS : 26
DAIDZEIN SUPPRESSES MACROPHAGE LPS-INDUCED INFLAMMATORY RESPONSE VIA DEPRESSING STAT-3 AND P-38 MAPK TRANSCRIPTIONAL ACTIVITY : 27
DIFFERENCES OF PERIPHERAL OPIOID ANTINOCICEPTION TO MECHANICAL AND THERMAL STIMULI : 28
STUDY OF THE EFFECT OF CHONDROITIN SULFATE ON PAIN IN KNEE OSTEOARTHRITIS PATIENTS ASSESSED BY FUNCTIONAL MRI: A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED CLINICAL TRIAL : 29
PHENOTYPIC AND PROLIFERATIVE DIFFERENCES OF MOUSE MESENCHYMAL STEM CELLS FROM ADIPOSE TISSUE : 30
TRANSIENT RECEPTOR POTENTIAL CHANNELS PRESYNAPTICALY MODULATE COLON MOTILITY : 31
CHARACTERIZATION OF LATER STAGES OF INFLAMMATION IN THE MOUSE AIR POUCH MODEL IN C57BL/6 MICE : 32
HYPERNOCICEPTIVE RESPONSES FOLLOWING THE INTRATIBIAL INOCULATION OF RM-1 PROSTATE CANCER CELLS IN MICE : 33
INVOLVEMENT OF THE NO/PKG/KATP CHANNEL PATHWAY IN THE ANTIHYPERALGESIC EFFECT OF THE CB2 RECEPTOR AGONIST, AM1241, IN MICE INOCULATED WITH TUMORAL NCTC 2472 CELLS : 34
INHIBITION OF PERIPHERAL SIGMA-1 RECEPTORS REVERSES INFLAMMATORY HYPERALGESIA IN MICE : 35
N- AND C-TERMINAL PARATHYROID HORMONE-RELATED PROTEIN DOWN-REGULATE THE PRODUCTION OF INFLAMMATORY MARKERS IN OSTEOARTHRITIC HUMAN OSTEOBLASTS : 36
MANGIFERA INDICA LEAF EXTRACT, RICH IN POLYPHENOLIC COMPOUNDS, PROTECTS AGAINST DEXTRAN SULFATE SODIUM-INDUCED COLITIS IN MICE : 37
PARADOXICAL FACILITATION OF CATECHOLAMINE SECRETION, INDUCED BY THE COMBINATION OF ATP AND METHIONINE - ENKEPHALIN IN CHROMAFFIN CELLS STIMULATED WITH ACETYLCHOLINE AT 37°C : 38
TARGETED NANOPARTICLES ACROSS THE BLOOD BRAIN BARRIER : 39
BEHAVIOURAL CHARACTERIZATION OF 5-HT4 RECEPTOR KNOCKOUT MICE: IMPLICATIONS FOR ANXIETY AND DEPRESSION : 40
THE CONTRIBUTION OF 5-HT4 RECEPTORS TO THE ANXIETY/DEPRESSION MANIFESTATIONS IN TWO ANIMAL MODELS OF DEPRESSION : 41
NEUROPROTECTIVE PROFILE OF THE NEW GLYCOLIPID COMPOUND IG20 IN RAT HIPPOCAMPAL SLICES : 42
EFFECTS OF D1 RECEPTOR BLOCKADE ON THE BRAIN METABOLISM AND NEURODEGENERATION INDUCED BY THE LITHIUM-PILOCARPINE MODEL OF EPILEPSY : 43
STIMULATION OF IGF-II RECEPTOR INDUCES NEUROPROTECTION AGAINST OXIDATIVE DAMAGE ON ADULT CORTICAL NEURONAL CULTURES : 44
NEW DUAL NEUROPROTECTANTS BASED ON 3-SUBSTITUTED INDOLE DERIVATIVES TARGETING BOTH CALCIUM CHANNELS AND PHOSPHOPROTEIN PHOSPHATASE 2A : 45
EFFECT OF BUSPIRONE ON THE SUBTHALAMIC NUCLEUS ON AN ANIMAL MODEL OF PARKINSON'S DISEASE: AN ELECTROPHYSIOLOGICAL STUDY : 46
PHARMACOLOGICAL CHARACTERIZATION OF 5-HT7 SELECTIVE ARYLPIPERAZINE DERIVATIVES IN RAT PRIMARY ASTROCYTES : 47
EFFECT OF INTENSIVE AND REPEATED USE OF ETHANOL ON THE INTEGRITY OF BLOOD- BRAIN BARRIER IN MOUSE BRAIN. ROLE OF TOLL-LIKE RECEPTOR 4 (TLR4) : 48
DISRUPTION OF BLOOD-BRAIN BARRIER INTEGRITY IN POSTMORTEM HUMAN ALCOHOLIC BRAIN : 49
EFFECT OF MDMA ON AQP4 EXPRESSION IN ASTROCYTIC ENDFEET AND TPA ACTIVITY IN RAT HIPPOCAMPUS : 50
DIFFERENTIAL REGULATION OF SYNAPTIC PLASTICITY MARKERS AND BEHAVIOUR BY HISTONE DEACETYLASE INHIBITORS : 51
SMALL SYNTHETIC HYALURONAN DISACCHARIDES AFFORD NEUROPROTECTION IN BRAIN ISCHEMIA RELATED MODELS : 52
IMPLICATION OF AMYLOID -β PEPTIDE-INDUCED DECREASES OF VGLUT1 EXPRESSION IN THE COGNITIVE DEFICITS OF ALZHEIMER'S DISEASE : 53
INCREASED ACTIVATION OF JNK3 IN ALZHEIMER'S DISEASE : 54
ALCOHOL POTENTIATES THE REINFORCING EFFECTS OF MEPHEDRONE IN ADOLESCENT MICE. ROLE OF D3 RECEPTORS : 55
IG20, A NEW GLYCOLIPID, INCREASES THE MEMBRANE EXCITABILITY AND EXOCYTOSIS IN CHROMAFFIN CELLS : 56
BIOACTIVE PROPERTIES OF STEVIA ETHANOLIC EXTRACT: ANTIPROLIFERATIVE EFFECTS ON HELA CELLS AND ANTIOXIDANT ACTIVITY : 57
PHARMACOLOGICAL STUDY OF JASONIA GLUTINOSA IN SMOOTH MUSCLE OF RAT DUODENUM : 58
ANTIHYPERTENSIVE AND DIURETIC EFFECTS OF A FRAXINUS EXCELSIOR L. SEED EXTRACT ON SPONTANEOUSLY HYPERTENSIVE RATS : 59
INHIBITORY EFFECT OF NARINGENIN AND NARINGIN ON IL-6 AND IL-8 RELEASE : 60
ANTI-PROLIFERATIVE AND CYTOTOXIC EFFECTS OF GRAPE POMACE AND GRAPE SEED EXTRACTS ON COLORECTAL CANCER CELL LINES : 61
T -RESVERATROL PROTECTS ENDOTHELIUM-DEPENDENT RELAXATION IN ISOLATED RAT AORTA ACUTELY EXPOSED TO HIGH GLUCOSE : 62
ESTIMATION OF TOTAL FLAVONOID CONTENT IN SIDERITIS HYSSOPIFOLIA : 63
EFFECTS OF AN EGG WHITE HYDROLYSATE IN DIFFERENT ANTHROPOMETRIC AND CARDIOVASCULAR ALTERATIONS IN AN EXPERIMENTAL MODEL OF METABOLIC SYNDROME INDUCED BY DIET : 64
OXIDATIVE STRESS AND INFLAMMATORY MARKET AFTER ORAL TREATMENT OF DIFFERENT DOSE OF HYDROXYTYROSOL : 65
EFFECT OF NITRODERIVATIVES OF HYDROXYTYROSOL ON OXIDATIVE STATUS AND CATECHOL- O -METHYL TRANSFERASE ACTIVITY IN RAT'S TISSUE : 66
EFFECTS OF ANTHOCYANIDINS ON ASTROCYTES OVER OXIDATION MARKERS AND CELL INJURY INDUCED BY MPTP NEUROTOXIN : 67
ANTI-INFLAMMATORY EFFECTS OF MITRAPHYLLINE ON MACROPHAGE ACTIVATION: SKEW TOWARD M2 PHENOTYPE : 68
PHOTOPROTECTIVE EFFECT OF GLYCOSYLGLYCEROLS AND GLYCOLIPIDS FROM MICROALGAE IN HACAT KERATINOCYTES : 69
DETERMINATION OF POLYPHENOL CONTENTS IN TEA AND HERBAL INFUSIONS : 94
INVESTIGATION OF THE DIMERIZATION INTERFACE OF THE SEROTONIN 5-HT2A RECEPTOR BY COMPUTATIONAL AND EXPERIMENTAL APPROACHES : 70
AGE-RELATED CHANGES IN THE INHIBITION OF SUPEROXIDE ANION LEVELS FROM PERITONEAL LEUKOCYTES BY ALLOPURINOL AND APOCYNIN : 71
TEM LYMPHOCYTES ARE THE SPECIFIC TARGET OF THE SCORPION TOXIN VM24 : 72
PPARβ/δ REGULATES FGF21 IN HEPATOCYTES : 73
DELETION OF THE INSULIN RECEPTOR SUBSTRATE 2 (IRS2) MODIFIES THE ACTIONS OF DOPAMINE IN MOUSE ADIPOCYTES : 74
STUDY OF POTENTIAL BIOMARKERS AND TARGETS IN HUMAN MORBID OBESITY: PLEIOTROPHIN AND MIDKINE : 75
RADIOGRAPHICAL ANALYSIS OF MORPHINE EFFECT ON GASTROINTESTINAL MOTOR FUNCTION IN CONSCIOUS RATS : 76
CELL KINETIC IN PROXIMAL COLON: DOSE-RESPONSE EFFECTS OF DIETS SUPPLEMENTED WITH 0.7% OR 7% PLANTAGO OVATA HUSK IN HEALTHY MICE AND IN THE EARLY STAGES OF COLORECTAL CARCINOGENESIS : 77
EFFECT OF POLYMORPHISMS ON THE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF RISPERIDONE IN HEALTHY VOLUNTEERS : 78
RELATIONSHIP BETWEEN CYP2D6 GENOTYPE AND HALOPERIDOL PHARMACOKINETICS AND EXTRAPYRAMIDAL SYMPTOMS IN HEALTHY VOLUNTEERS : 79
PHARMACEUTICAL CARE AND PHARMACOGENETIC APPROACH FOR A BETTER UNDERSTANDING OF TACROLIMUS METABOLISM : 80
GENETIC POLYMORPHISMS CAN PREDICT KNEE OSTEOARTHRITIS PROGRESSION. RESULTS FROM THE ARTHROTEST MULTICENTER ASSOCIATION STUDY : 81
ROLE OF TAP1 AND TAP2 POLYMORPHISMS IN AMOXICILLIN-CLAVULANATE HEPATOTOXICITY (AC DILI) : 82
TYK2: A POSSIBLE TARGET TO TREAT MODERATE-TO-SEVERE PSORIASIS : 83
CT-1 PREVENTS GENTAMICIN-INDUCED ACUTE KIDNEY INJURY : 84
URYNARY REGIIIβ: A DIFFERENTIALLY MARKER OF ACUTE KIDNEY INJURY INDUCED BY GENTAMICIN : 85
HERBALS AND DIETARY SUPPLEMENT (HDS) PRODUCTS: A GROWING CAUSE OF HEPATOTOXICITY IN THE SPANISH DILI REGISTRY : 86
DRUGS IN SPECIAL SITUATIONS. EVIDENCE LEVELS TO GUIDE PEDIATRIC PRESCRIPTIONS : 87
TOXICOKINETIC-TOXICODYNAMIC RELATIONSHIP IN CASES OF PYRETHROID EXPOSURE : 88
CYTOSOLIC AND ENDOPLASMIC RETICULUM CALCIUM SIGNALS EVOKED BY TWO TYPES OF CHONDROITIN SULFATES : 89
QUESTIONS ORDER MANIPULATION WITH RESPECT TO LEARNED-KNOWLEDGE ORDER MAY CONDITION THE SCORE IN MULTIPLE-CHOICE QUESTION ASSESSMENT : 90
DEVELOPMENT OF A MINI-GRAPHIC ATLAS OF MECHANISMS OF ACTION OF DRUGS MADE BY STUDENTS : 91
ACQUISITION OF SKILLS AND ABILITIES IN PHARMACOLOGY: PREFERENCES OF UNDERGRADUATE MEDICAL STUDENTS : 92
UNDERSTANDING DRUG MECHANISMS OF ACTION: EFFECTIVENESS OF A LEARNING MULTIMEDIA TOOL : 93
TUTORING AS TOOL TO IMPROVE LEARNING OUTCOMES IN PHARMACOLOGY : 95
ASSESSING STUDENTS' OPINION AND SATISFACTION ON PHARMACOLOGY IN NURSING DEGREE : 96
RESOLUTION OF CLINICAL CASE STUDIES IN THE DEGREE OF PHARMACY BY USING “AULA VIRTUAL” OF UNIVERSITY OF MURCIA : 97
LEARNING TO RESEARCH IN PHARMACOLOGY USING WEB 2.0 TECHNOLOGIES : 98
ASSESSMENT AND COMPARISON OF THE ANTIOXIDANT ACTIVITIES OF COMMERCIAL DIETARY SUPPLEMENTS USED TO IMPROVE MALE INFERTILITY : 99
PITX2 DECREASES L-TYPE CA2+ CURRENT AND INCREASES THE SLOW DELAYED RECTIFIER K+ CURRENT IN CARDIAC CELLS : 100
NAV1.5 N-TERMINUS EXHIBITS A PDZ BINDING DOMAIN AND INCREASES THE KIR2.1 CHANNEL DENSITY : 101
GRAPHENE DERIVATIVES AS SCAFFOLD FOR EX VIVO SURVIVAL AND MATURATION OF DOPAMINERGIC SN4741 CELLS : 102
THE EFFECTS OF TREATMENT ON DISEASE SYMPTOMS AND PROGRESSION OF STRUCTURAL CHANGES IN KNEE OSTEOARTHRITIS PARTICIPANTS FROM THE OSTEOARTHRITIS INITIATIVE PROGRESSION COHORT : 103
ANTIFUNGAL ACTIVITY IN VITRO OF STATINS: A COMPARATIVE STUDY OF SIMVASTATIN, FLUVASTATIN, LOVASTATIN, PRAVASTATIN AND ATORVASTATIN AGAINST CANDIDA : 104
ALCOHOL AND TOBACCO CONSUME DURING PREGNANCY AFTER NATURAL AND IN VITRO FERTILIZATION CONCEPTION : 105